Tissue effects of saw palmetto and finasteride: Use of biopsy cores for in situ quantification of prostatic androgens

Urology

Volumn 57, Issue 5, 2001, Pages 999-1005

  Marks, Leonard S ^a,b   Hess, David L ^c   Dorey, Frederick J ^d   Luz Macairan, Maria ^a   Cruz Santos, Paul Bryan ^a   Tyler, Varro E ^e  

^a Urological Sci Research Foundation   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FINASTERIDE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SABAL; TRANSURETHRAL RESECTION;

AGED; ANDROGEN ANTAGONISTS; BIOPSY, NEEDLE; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; PROSTATE; PROSTATIC HYPERPLASIA; SERENOA; TESTOSTERONE; TREATMENT OUTCOME;

EID: 0035030610     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01052-9     Document Type: Article

References (22)

1. Phytotherapy in treatment of benign prostatic hyperplasia; a critical review
2. Saw palmetto for the treatment of men with lower urinary tract symptoms
3. Saw palmetto extracts for treatment of benign prostatic hyperplasia; a systematic review
4. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia
5. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia
6. Prostatic growth; new insights into hormonal regulation
7. Effects of long term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia
8. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5α-reductase activity in human benign prostatic hyperplasia
9. Inhibition of androgen metabolism and binding by a liposterolic extract of 'Serenoa Repens B' in human foreskin fibroblasts
10. Comparison of finasteride (Proscar), a 5α-reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α-reductase inhibitors
11. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-α reductase in healthy male volunteers
12. Estrogens in fetal and maternal plasma of the rhesus monkey
13. A quantitative analysis of the physiological role of estradiol and progesterone in the control of tonic and surge secretion of luteinizing hormone in the rat
14. Sex steroids in the umbilical circulation of fetal rhesus monkeys from the time of gonadal differentiation
15. Prostatic effects induced in dogs by chronic or acute oral administration of 5α-reductase inhibitors
16. Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia
17. Dihydrotestosterone measured in core biopsies from prostatic tissues
18. The effect of finasteride in men with benign prostatic hyperplasia
19. Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia; results from the North American phase III clinical trial
20. Evidence of atrophy and apoptosis in the prostates of men given finasteride
21. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
22. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia